search
Back to results

Evaluation of the Respiratory Function in Renal Transplanted Children (SPIROKID)

Primary Purpose

Respiratory Tract Disease, Kidney Transplantation, Pediatric

Status
Unknown status
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
pulmonary function
Sponsored by
Nantes University Hospital
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional other trial for Respiratory Tract Disease focused on measuring Children, transplanted, kidney transplantation, respiratory function, pulmonary function tests, respiratory disease, immunosuppression

Eligibility Criteria

2 Years - 20 Years (Child, Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Renal transplanted
  • Patients of 2 to 20 years old
  • Followed in one the five centers mentionned above (Nantes, Necker, Robert Debré, Lyon, Lille)

Exclusion Criteria:

  • Disaggrement from the patient and/or his/her legal representant
  • Impossibility to do the pulmonary function test
  • Cystic fibrosis
  • Patient with another transplant (heart, lung, liver)

Sites / Locations

  • CHRU LilleRecruiting
  • Hospices Civiles de LyonRecruiting
  • CHU de NantesRecruiting
  • Hôpital Universitaire Necker Enfants MaladesRecruiting
  • Robert Debre HospitalRecruiting

Outcomes

Primary Outcome Measures

Respiratory alteration
An alteration of the pulmonary function tests (PFT) values or the presence of chronic respiratory symptoms/treatment (questionnaire)

Secondary Outcome Measures

risk factors linked to an alteration of the respiratory function
We will analyse the relation between several exposure variables or the potential risk factors (medical past, medication, infectious diseases,...) and the presence of an alteration of the respiratory function. Clinical datas will be gathered thanks to a questionnaire on the medical past and the respiratory state of the child. The usual biological measures will be done at the annual check up (exploring immunity, pharmacological dosages, renal function, for example).

Full Information

First Posted
May 31, 2018
Last Updated
June 17, 2021
Sponsor
Nantes University Hospital
Collaborators
Lille University Hospital, Hospices Civils de Lyon, NECKER UNIVERSITY HOSPITAL, Hopital Universitaire Robert-Debre
search

1. Study Identification

Unique Protocol Identification Number
NCT03571542
Brief Title
Evaluation of the Respiratory Function in Renal Transplanted Children
Acronym
SPIROKID
Official Title
Evaluation of the Respiratory Function in Renal Transplanted Children : a Prospective, Multicenter French Study
Study Type
Interventional

2. Study Status

Record Verification Date
June 2021
Overall Recruitment Status
Unknown status
Study Start Date
July 16, 2018 (Actual)
Primary Completion Date
July 16, 2022 (Anticipated)
Study Completion Date
July 16, 2022 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Nantes University Hospital
Collaborators
Lille University Hospital, Hospices Civils de Lyon, NECKER UNIVERSITY HOSPITAL, Hopital Universitaire Robert-Debre

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Objectives: While a respiratory abnormality was found in 50% of pediatric renal transplant recipients in a study conducted in Belgium and the Netherlands in 2008, the respiratory status of transplanted children in France remains unknown. The primary objective of this study is to assess the prevalence of respiratory impairment and its characteristics in children with renal transplant. The secondary objective is to study its association with some potential risk factors such as immunosuppressive therapy or humoral immunodeficiency. Methodology: This interventional study aims to recruit the 385 children currently being followed by 5 French pediatric renal transplant centers between June 2018 and November 2019. A clinical and functional respiratory assessment will be carried out during the routine annual follow-up of the transplant recipient. Children with clinical signs of concern or abnormal spirometry will be referred to a respiratory specialist. Pharmacokinetic assays of immunosuppressant therapy and the exploration of humoral function will also be performed. The prevalence and type of respiratory abnormalities will be described. Logistic regression will be used to explore the association between potential risk factors and impaired respiratory function. Expected results: This study will be the first to evaluate the respiratory status of children with renal transplants in France. The prospective, multi- centered nature of the study, in addition to the large cohort size (which represents two thirds of children with renal transplants in France) will guarantee current, reliable, and representative data for the target population. We will provide new knowledge by precisely characterizing the type of lung injury and looking for potential risk factors. If our study confirms the high prevalence of pulmonary impairment in children with renal transplants, systematic monitoring of respiratory function may be recommended to enable early diagnosis and management. The expected individual and public health benefits would be significant by limiting the appearance of long-term, irreversible sequelae (such as non-cystic-fibrosis bronchiectasis) and improving the quality of life of these patients.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Respiratory Tract Disease, Kidney Transplantation, Pediatric
Keywords
Children, transplanted, kidney transplantation, respiratory function, pulmonary function tests, respiratory disease, immunosuppression

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
385 (Anticipated)

8. Arms, Groups, and Interventions

Intervention Type
Other
Intervention Name(s)
pulmonary function
Intervention Description
The aim of this study is to assess the respiratory function thanks to pulmonary function tests in renal transplanted children in France.
Primary Outcome Measure Information:
Title
Respiratory alteration
Description
An alteration of the pulmonary function tests (PFT) values or the presence of chronic respiratory symptoms/treatment (questionnaire)
Time Frame
at the inclusion
Secondary Outcome Measure Information:
Title
risk factors linked to an alteration of the respiratory function
Description
We will analyse the relation between several exposure variables or the potential risk factors (medical past, medication, infectious diseases,...) and the presence of an alteration of the respiratory function. Clinical datas will be gathered thanks to a questionnaire on the medical past and the respiratory state of the child. The usual biological measures will be done at the annual check up (exploring immunity, pharmacological dosages, renal function, for example).
Time Frame
at the inclusion

10. Eligibility

Sex
All
Minimum Age & Unit of Time
2 Years
Maximum Age & Unit of Time
20 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Renal transplanted Patients of 2 to 20 years old Followed in one the five centers mentionned above (Nantes, Necker, Robert Debré, Lyon, Lille) Exclusion Criteria: Disaggrement from the patient and/or his/her legal representant Impossibility to do the pulmonary function test Cystic fibrosis Patient with another transplant (heart, lung, liver)
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Alexandra BRUEL
Phone
0240083566
Email
alexandra.bruel@chu-nantes.fr
First Name & Middle Initial & Last Name or Official Title & Degree
Tiphaine BIHOUEE
Phone
0240083333
Email
tiphaine.bihouee@chu-nantes.fr
Facility Information:
Facility Name
CHRU Lille
City
Lille
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Robert NOVO
Facility Name
Hospices Civiles de Lyon
City
Lyon
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Anne-Laure SELLIER
Facility Name
CHU de Nantes
City
Nantes
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Alexandra BRUEL, Dr
Facility Name
Hôpital Universitaire Necker Enfants Malades
City
Paris
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Laurène DEHOUX
Facility Name
Robert Debre Hospital
City
Paris
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Véronique BAUDOUIN, Dr

12. IPD Sharing Statement

Learn more about this trial

Evaluation of the Respiratory Function in Renal Transplanted Children

We'll reach out to this number within 24 hrs